课题基金 / 基金详情

The use of highly prolactin-elevating antipsychotics and the risk of ovarian and endometrial cancer

The use of highly prolactin-elevating antipsychotics and the risk of ovarian and endometrial cancer
使用高度催乳素升高的抗精神病药物与卵巢癌和子宫内膜癌的风险
批准号：
254826
负责人：
Azoulay Laurent
金额：
$8.55万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=254826&lang=en
关键词：
Database Endometrial Cancer Gprd Ovarian Cancer

项目摘要

项目成果

Azoulay Laurent的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
While antipsychotics have been used successfully for a number of psychiatric disorders, there is some evidence which suggests that they may possibly, via their sustained elevation of prolactin levels, increase the risk of endometrial and ovarian cancer. T
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study
Cancer pharmacoepidemiology: a population-based assessment of the risks of prescription drugs in vulnerable populations
The use of beta-blockers and the prevention of cancer-specific mortality
The use of glyburide and the risk of cancer in elderly patients with type 2 diabetes
海外基金